Santikos Suite offers capability to study Alzheimer’s, other diseases

October 5, 2017

William L. Henrich, M.D., MACP, president of UT Health San Antonio, recognized the John L. Santikos Charitable Foundation, a fund of the San Antonio Area Foundation, on Oct. 2 for its $2.3 million gift to build the John L. Santikos CT and Nuclear Medicine Suite at the university. The state-of-the-art imaging suite is on the […]

President William L. Henrich, M.D., MACP, UT Health San Antonio


Why can’t mTOR inhibitors kill cancer? Study explains

October 3, 2017

Anti-cancer drugs called mTOR inhibitors slow the growth of cancer cells but show limited ability to cause cancer cell death. New studies explain why. Masahiro Morita, Ph.D., assistant professor of molecular medicine in the Joe R. & Teresa Lozano Long School of Medicine at UT Health San Antonio, contributed to the research. He is a […]




Drug Dealer, MD: Overprescription and the Opioid Crisis in America

October 2, 2017

WHAT:  Drug Dealer, MD: How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop   WHEN:  5:30 to 7 p.m. Thursday, Oct 5   WHERE: UT Health San Antonio Pestana Lecture Hall, 7703 Floyd Curl Drive, San Antonio, Texas 78229   WHO: Anna Lembke, M.D.   NOTE: Free and open to […]

Opioids


UT Health San Antonio psychiatrist lead author on study showing major improvement in children’s ADHD symptoms

October 2, 2017

Time-release formulation designed for children with severe ADHD symptoms upon awakening SAN ANTONIO (Oct. 2, 2017) ― UT Health San Antonio psychiatrist Steven Pliszka, M.D., is lead author on a study that shows a new formulation of an established medication for attention deficit hyperactivity disorder (ADHD) significantly improves severe morning symptoms. Dr. Pliszka is the Dielmann Distinguished […]

Brain


Greehey Institute contributes to survey of RAS-sensing antibodies

September 28, 2017

Researchers from the Greehey Children’s Cancer Research Institute at UT Health San Antonio are co-authors on a paper published Sept. 26 in Science Signaling, a high-impact journal that is part of the Science family of journals. RAS mutations are implicated in several cancers, including lung, colorectal and pancreatic ductal carcinoma. The three RAS genes are […]

Erase Cancer